This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Group B Streptococcus (GBS) Disease
and you are
between 20 and 42
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study looks at the body's immune response to a GBS vaccine 2 years after the orginal vaccine(s) were given in the V98P2 study. Blood will be drawn and evaluated for GBS antibody levels.

Provided treatments

  • Biological: Group B streptococcus (GBS) vaccine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01053767. The sponsor of the trial is Novartis Vaccines and it is looking for 95 volunteers for the current phase.
Official trial title:
A Phase I Extension Study to Assess the Long-Term Persistence of GBS Serotypes Ib and III Antibodies in Women Previously Immunized With a GBS Ib and III Crm-Glycoconjugate Vaccine